top of page

Spotlight: October-November 2022

Updated: Dec 7, 2022

Words by Isabel O'Brien

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering major acquisitions, landmark trials, significant drug approvals and much more

05 October

Pfizer acquires Global Blood Therapeutics to advance sickle cell disease research

17 October

Moderna updates 2022 supply agreement with Gavi to secure variant-specific COVID-19 vaccines for 92 LMICs

18 October

Eli Lilly announces definitive agreement to acquire precision genetic medicine company Akouos

20 October

Takeda collaborates with Zedira and Dr Falk Pharma to develop first-in-class coeliac disease therapy

03 November

Pharma CEOs form first-of-its-kind task force to achieve emission reduction and net zero targets

09 November

Ipsen’s Onivyde for metastatic pancreatic cancer meets primary endpoints in Phase 3 trial

15 November

Access to Medicine Index 2022 reveals significant progress in access strategies, with GSK retaining the top spot

17 November

ABPI uses World Antibiotic Awareness Week to urge the pharma industry to develop new antibiotics

18 November

US anti-abortionists launch lawsuit to overturn FDA approval of abortion drug mifepristone

22 November

FDA approves Hemgenix, the first gene therapy to treat adults with haemophilia B

23 November

First-ever molecule targeting an RNA methyltransferase enzyme enters Phase I trial at STORM Therapeutics

24 November

Roche, Cancer Research UK and The University of Manchester begin multi-drug, precision medicine trial for rare cancers

This news round up features in GOLD 25 – read the full issue here.

Read next

Subscribe to GOLD


Sign up to receive a weekly roundup of our latest articles, interviews and more 

bottom of page